BrainSightAI

The Montreal Cognitive Assessment (MoCA) is a brief, 30-question test that helps healthcare professionals detect cognitive impairments very early on, allowing for faster diagnosis and patient care. MoCA empowers healthcare professionals and researchers to detect cognitive impairment related to conditions such as Alzheimer's disease, Parkinson's disease, Huntington's disease, Lewy Body Dementia, VCI/Stroke, frontotemporal dementia, brain metastasis, ALS, sleep behavior disorder, brain tumors, multiple sclerosis, head trauma, depression, schizophrenia, heart failure, substance abuse, HIV, COVID, and more. MoCA is regularly used by nurses, primary care and specialty physicians, occupational therapists, speech-language pathologists, psychologists, researchers, and other clinicians. It quickly and accurately assesses short-term memory, visuospatial abilities, executive functions, attention, concentration and working memory, language, and orientation to time and place.

IntelliSpace Portal 9.0, with over 70 clinical applications in total, is an advanced visualization platform that offers a single integrated solution to help you work quickly and efficiently with increased diagnostic confidence – especially during reading and follow-up of multi-faceted cases. With the aging population, neurodegenerative disease is on the rise worldwide. Since neurological disorders are often chronic, patients require long-term follow-up, but changes in the brain can be subtle and hard to detect. IntelliSpace Portal 9.0 offers a host of new and enhanced neuro applications such as NeuroQuant®¹,LoBi and CT Brain Perfusion. These tools are designed to facilitate rapid, objective, quantitative and consistent image evaluation. Given the increasing interest in pulmonary care, IntelliSpace Portal 9.0 offers you one comprehensive toolset to help you track pulmonary disease from detection to follow-up.